Within the framework of the Pilot Procurement Project for Quality and Sourcing of HIV Drugs, the International Pharmacopoeia is collaborating with manufacturers, independent analytical drug quality control laboratories, national and regional pharmacopoeial bodies, research, governmental and regulatory bodies, to provide specifications and monographs for the following antiretroviral agents:

abacavir, didanosine, efavirenz, indinavir, lamivudine, nelfinavir, nevirapine, ritonavir, saquinavir, stavudine, zidovudine

It is planned to develop specifications for the respective dosage forms in a second phase of the project. The first draft monograph, didanosine, is now available for consultation as presented below. Comments are welcome and should be sent to: Quality and Safety: Medicines, World Health Organization, 1211 Geneva 27, Swtizerland or: kopps@who.int